FDA warns of problems with blood-glucose monitors

The Food and Drug Administration is warning that several blood-glucose testing systems made by Johnson & Johnson for people with diabetes have problems that could cause users to misinterpret their blood-glucose results. Johnson & Johnson's unit, LifeScan, said it would temporarily stop shipments of the OneTouch Ultra, InDuo and OneTouch FastTake meters and notify patients who have used the monitor.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN